Dates: April 12 and 13, 2019
Location: Yale University
Meeting description: More than 1 in 3 people will be diagnosed with cancer during their lifetime, and deaths from the disease are estimated to reach nearly 600,000 in the U.S. alone in 2017. The vast majority of cancer deaths are due to the evolution of therapeutic resistance and metastasis. This emergence of therapy-resistant, metastatic cancer is an evolutionary process, in which a genetically diverse population of cancer cells is subject to selective forces within the body.
This meeting seeks to bridge the gap between the molecular evolutionary community and the cancer biology field. It brings together experts and thought leaders from diverse fields, including molecular biology, cancer biology, genomics, phylogenetics, and evolutionary biology, to address a significant health issue.
Registration is free and space is limited!
Jeffrey P. Townsend, Elihu Associate Professor of Biostatistics and of Ecology & Evolutionary Biology, Yale University